Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-25

Clinical Trial Update: Exercise to Boost Response to Checkpoint Blockade Immunotherapy [NA]

View source ↗

Summary

Clinical trial update describes an active-not-recruiting study investigating whether exercise can boost response to checkpoint blockade immunotherapy in skin ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: AdventHealth Translational Research Institute | Conditions: Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma | NA | Status: ACTIVE_NOT_RECRUITING